載入...
UGT2B28 genomic variation is associated with hepatitis B e-antigen seroconversion in response to antiviral therapy
Seroconversion of hepatitis B virus (HBV) e-antigen (HBeAg) is a critical but often-missed therapeutic goal in standard antiviral treatments. An extreme-phenotype genome-wide association study was performed, comparing untreated spontaneous recoverers (with seroconversion of HBV surface antigen) vers...
Na minha lista:
| 發表在: | Sci Rep |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5036189/ https://ncbi.nlm.nih.gov/pubmed/27665939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep34088 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|